I understand where your coming from Tanis being here for a

New Post Public Reply Private Reply Replies (0) Message Board
jamiejaytrader Tanis2476 #23848
I understand where your coming from Tanis being here for a couple of years myself and experienced everything myself too. But i do think this time is different because the JV is mentioned in a 8K instead of twitter from GC.

Quote:
If a JV partnership with cash is so close, why make the announcement for a potential 1:300 RS?


I think it might be for 2 reasons.

1) negotiations - willing to show the interested party they are willing to finance it by themselves if need be.

2) RS is a backup plan in case a JV doesn't happen.

But seeing how MNK just bought Stratatech with their burn product, who's to say that if this JV with this certain party falls through, others can still take a huge interest in ESS and a deal can still be made with an other party after they realize that ESS has value (indirectly through the MNK deal with Stratatech).

Say for example MNK paid $200 million for Stratatech then i would think our product should be say worth (i'm really just throwing a low number in my eyes here) $60 million.

Our market cap is $3 million so if ESS would be easily worth $60 million then thats a 20-bagger from the pps we are at now!!

And i personally believe MNK paid more then $200 million because of the following statement in their press release:

Quote:
Dilution Consideration and Closing
The strength of Mallinckrodt's overall business is expected to offset slight dilution to the company's near- and longer-term adjusted diluted earnings per share


As an MNK investor i know that MNK makes a load boat of money (see quote below) each quarter.
$200 million dollars is easily made within a quarter so some kind of dilution would suggest to me that the deal is a lot higher money wise then the $200 million i'm taking for my example. It could also be they do part money and stock or else i don't understand the dilution part in the PR.

Quote:
In the first nine months of fiscal 2016, Mallinckrodt generated $994.4 million in operating cash flow and $860.9 million in free cash flow, with $412.2 million in free cash flow in the third quarter alone.


Not so long ago MNK just bought 3 products with cash they generated in a quarter from memory.

Another reason is i recall reading that Stratagraft could earn 300million in america alone (market potential). So i think $200 million would still be a low ball offer for MNK for stratatech.

Just some thoughts and i'm not saying i'm right but thats how i look at our current situation.

Investorxc's post to me a couple days back made me do some re-thinking and i decided to average down my position with a small amount of money.
I got my average down from $2.28 to $1.67 at the moment with hardly any cash considering how much money i already have invested and lost so far.

Lets hope this time will be different with ambs then what we have experienced before. I'm crossing my fingers for a good outcome this time!

Have a good weekend.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading

Top 5 Most Recently Viewed Articles

Lesaka Technologies Set to Review Year-End Performance Soon

Updated Category News Views 190

Lesaka Technologies to Host Year-End Results Webcast Lesaka Technologies, Inc. (NASDAQ: LSAK) is gearing up to release its fourth quarter and year-end results for 2025, an event anticipated by investors and analysts alike. This significant announcement will come shortly after the U.S. market closes on September 10, 2025. On the following day, the company's management will...

Continue Reading
RYVYL Inc. Reports Strong Revenue Growth in Q3 2024

Updated Category News Views 149

RYVYL Inc. Reports Strong Revenue Growth in Q3 2024 RYVYL Inc. (NASDAQ: RVYL), a pioneer in payment transaction solutions utilizing proprietary blockchain technology, has showcased its performance for the third quarter ended September 30, 2024. The latest results indicate exciting upward trends and milestones for the company. Third Quarter Highlights and Growth Drivers...

Continue Reading
NASA Selects Metis Technology Solutions for Key Contract Role

Updated Category News Views 171

Navigating New Frontiers in Aerospace Contracts NASA, the renowned leader in space research and exploration, recently made headlines by selecting Metis Technology Solutions Inc. to spearhead engineering and simulation services. This landmark decision signals a commitment to advancing aerospace research and development across various vital projects. Insights Into the ARTS...

Continue Reading
Investigation into Data Breach at True World Holdings

Updated Category News Views 150

Investigation into Data Breach at True World Holdings In a troubling development, Federman & Sherwood has launched an investigation concerning a data breach affecting True World Holdings LLC. This seafood distributor, recognized for its vast network of supplying seafood to hotels and restaurants, has encountered serious cybersecurity issues that put personal information...

Continue Reading
Kevin Fuller Joins Nature's Sunshine as Global Marketing Leader

Updated Category News Views 211

Kevin Fuller Takes on the Role of Global Chief Marketing Officer Nature’s Sunshine Products, Inc. (NASDAQ: NATR), known for its top-tier herbal and nutritional supplements, has initiated a significant change with the appointment of Kevin Fuller as its Global Chief Marketing Officer. This vital decision underscores the company's commitment to expand its presence and...

Continue Reading